Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agents.
Sign Up to like & getrecommendations! Published in 2021 at "Expert opinion on biological therapy"
DOI: 10.1080/14712598.2021.1965985
Abstract: INTRODUCTION : There is very limited knowledge about the safety of COVID-19 vaccines in patients with psoriasis who are being treated with biological agents. We present our experience in 369 patients with moderate-to-severe psoriasis undergoing… read more here.
Keywords: patients psoriasis; covid vaccines; vaccines patients; therapy ... See more keywords
mRNA COVID‐19 vaccines in patients with chronic lymphocytic leukemia: A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Haematology"
DOI: 10.1111/ejh.13729
Abstract: In immunocompetent persons, the mRNA vaccines BNT162b2 and mRNA-1273 have been shown to be safe and efficacious against SARS-CoV-2 infection (1). However, most patients with B-cell malignancies, such as those with chronic lymphocytic leukemia (CLL),… read more here.
Keywords: mrna covid; covid vaccines; vaccines patients; chronic lymphocytic ... See more keywords
Prospective study of live attenuated vaccines for patients receiving immunosuppressive agents
Sign Up to like & getrecommendations! Published in 2020 at "PLoS ONE"
DOI: 10.1371/journal.pone.0240217
Abstract: Patients receiving immunosuppressive agents are at risk of life-threatening infections. However, live vaccines are generally contraindicated in them. We conducted a prospective study regarding live attenuated vaccines for them. Patients elder than one year of… read more here.
Keywords: attenuated vaccines; patients receiving; vaccines patients; immunosuppressive agents ... See more keywords
Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.846248
Abstract: Background Vaccine-induced immunity is essential for controlling the COVID-19 pandemic. Data on humoral and cellular immunogenicity and safety of different SARS-CoV-2 vaccines in patients with autoimmune rheumatic and musculoskeletal diseases (RMDs) are limited. Methods A… read more here.
Keywords: immunogenicity safety; safety; healthy controls; vaccines patients ... See more keywords
Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10060892
Abstract: Background: Severe acute respiratory syndrome coronavirus 2 disease (COVID-19) has caused a worldwide challenging and threatening pandemic. Multinational, placebo-controlled, observer-blinded trials were conducted since the beginning of pandemic because safe and effective vaccines were needed… read more here.
Keywords: tolerability covid; covid vaccines; vaccines patients; analysis ... See more keywords
Immunogenicity and Safety of mRNA Anti-SARS-CoV-2 Vaccines in Patients with Systemic Lupus Erythematosus
Sign Up to like & getrecommendations! Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10081221
Abstract: Vaccination is the most effective preventive measure to control the spread of COVID-19 and reduce associated complications. This study aims to evaluate the efficacy and safety of mRNA COVID-19 vaccines in patients with systemic lupus… read more here.
Keywords: vaccines patients; safety mrna; systemic lupus; lupus erythematosus ... See more keywords